Phytochemicals as Novel Therapeutics for Triple‐Negative Breast Cancer: A Comprehensive Review of Current Knowledge
Phytotherapy Research · 2025-01 · 39 (1) · 364-396
DOI: 10.1002/ptr.8376 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytotherapy Research, online erschienen am 12.11.2024. Verfasst von Zeeshan Ahmad Bhutta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry and Immunology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Republic of Korea. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Phytochemicals, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 298 Literaturangaben. Gefördert von: National Research Foundation of Korea, National Research Foundation.
Abstract (Originalsprache)
Triple‐negative breast cancer is a characteristic subtype of breast cancer that lacks the estrogen receptor, human epidermal growth factor receptor 2, and progesterone receptor. Because of its highly diverse subtypes, increased metastasis capability, and poor prognosis, the risk of mortality for people with triple‐negative breast cancers is high as compared with other cancers. Chemotherapy is currently playing a major role in treating triple‐negative breast cancer patients; however, poor prognosis due to drug resistance is causing serious concern. Recent studies on several phytochemicals derived from various plants being used in Traditional Chinese Medicine, Traditional Korean Medicine, Ayurveda (Traditional Indian Medicine), and so on, have demonstrated to be a promising agent as a viable therapy against triple‐negative breast cancer. Phytochemicals categorized as alkaloids, polyphenols, terpenoids, phytosterols, and organosulfur compounds have been demonstrated to reduce cancer cell proliferation and metastasis by activating various molecular pathways, thereby reducing the spread of triple‐negative breast cancer. This review analyzes the molecular mechanisms by which various phytochemicals fight triple‐negative breast cancer and offers a perspective on the difficulties and potential prospects for treating triple‐negative breast cancer with various phytochemicals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biochemistry and Immunology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Republic of Korea.
ORCID-Profile: Zeeshan Ahmad Bhutta, Kyung-Chul Choi
Förderung
- National Research Foundation of Korea
- National Research Foundation
Zitieren
APA
Bhutta, Z. A., & Choi, K. C. (2025). Phytochemicals as Novel Therapeutics for Triple‐Negative Breast Cancer: A Comprehensive Review of Current Knowledge. Phytotherapy Research, 39(1), 364-396. https://doi.org/10.1002/ptr.8376
Vancouver
Bhutta ZA, Choi KC. Phytochemicals as Novel Therapeutics for Triple‐Negative Breast Cancer: A Comprehensive Review of Current Knowledge. Phytotherapy Research. 2025;39(1):364-396. doi:10.1002/ptr.8376
BibTeX
@article{Bhutta2025,
author = {Bhutta, Zeeshan Ahmad and Choi, Kyung-Chul},
title = {Phytochemicals as Novel Therapeutics for Triple‐Negative Breast Cancer: A Comprehensive Review of Current Knowledge},
journal = {Phytotherapy Research},
year = {2025},
volume = {39},
number = {1},
pages = {364--396},
doi = {10.1002/ptr.8376}
}
EUVIMED